Carilex Medical (ROCO:7726) ROCE % : 9.15% (As of Jun. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Carilex Medical ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Carilex Medical's annualized ROCE % for the quarter that ended in Jun. 2024 was 9.15%.

Carilex Medical ROCE % Historical Data

The historical data trend for Carilex Medical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carilex Medical ROCE % Chart

Carilex Medical Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

ROCE %

27.65

17.44

14.55

18.45

Carilex Medical Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROCE %	Get a 7-Day Free Trial			16.25	12.97	24.10	15.32	9.15

Carilex Medical ROCE % Calculation

Carilex Medical's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	58.127	/	( ( (414.728 - 147.464)	+	(543.442 - 180.753) )	/ 2 )
	=	58.127	/	( (267.264	+	362.689)	/ 2 )
	=	58.127	/	314.9765
	=	18.45 %

Carilex Medical's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	31.72	/	( ( (543.442 - 180.753)	+	(513.555 - 182.532) )	/ 2 )
	=	31.72	/	( ( 362.689	+	331.023 )	/ 2 )
	=	31.72	/	346.856
	=	9.15 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

Carilex Medical (ROCO:7726) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Carilex Medical ROCE % Related Terms

Thank you for viewing the detailed overview of Carilex Medical's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Carilex Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carilex Medical Inc (ROCO:7726) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.77, Keji 1st Road, Guishan District, Taoyuan, TWN, 33383

Website

https://www.carilexmedical.com

Carilex Medical Inc is a company engaged in the wound care industry by developing leading-edge technology in the prevention and treatment of wounds. Their expertise is in research and development, manufacturing, and quality control and assurance allow us to provide unparalleled products in wound care management in the form of comprehensive product lines proven to prevent and manage pressure sores and wounds. They offer products in the form of Support Surfaces, Chair Cushion and Negative Pressure Wound Therapy.

Carilex Medical Headlines

No Headlines